US4604407A
(en)
*
|
1985-04-04 |
1986-08-05 |
E. R. Squibb & Sons, Inc. |
Hydroxamates
|
JPS61291555A
(ja)
*
|
1985-06-18 |
1986-12-22 |
Suntory Ltd |
N−置換グルタミン酸およびその用途
|
US5292937A
(en)
*
|
1986-03-31 |
1994-03-08 |
Rhone-Poulenc Inc. |
Use of malonic acid derivative compounds for retarding plant growth
|
US5123951A
(en)
*
|
1986-03-31 |
1992-06-23 |
Rhone-Poulenc Nederland B.V. |
Synergistic plant growth regulator compositions
|
GB8710362D0
(en)
*
|
1987-05-01 |
1987-06-03 |
Shell Int Research |
Anilide herbicides
|
US4824843A
(en)
*
|
1987-06-25 |
1989-04-25 |
Warner-Lambert Company |
Substituted amide inhibitors of cholesterol absorption
|
US4882357A
(en)
*
|
1988-07-15 |
1989-11-21 |
Warner-Lambert Company |
Novel N-(substituted-phenyl)-5-(substituted-2,5-dimethylphenoxy)-2,2-dimethylpentanamides
|
US4975456A
(en)
*
|
1988-07-15 |
1990-12-04 |
Warner-Lambert Company |
Novel N-(substituted-phenyl)-5-(substituted-2,5-dimethylphenoxy)-2,2-dimethylpentanamides
|
US5292922A
(en)
*
|
1990-08-22 |
1994-03-08 |
Central Glass Company, Limited |
N-acyl-N-phenyltetrahydrophthalamic acid derivatives, methods of producing same, and herbicides containing same as effective components
|
US7518013B2
(en)
*
|
2000-08-24 |
2009-04-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators
|
US7759520B2
(en)
*
|
1996-11-27 |
2010-07-20 |
University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
US6492554B2
(en)
|
2000-08-24 |
2002-12-10 |
The University Of Tennessee Research Corporation |
Selective androgen receptor modulators and methods of use thereof
|
US20050038110A1
(en)
*
|
2000-08-24 |
2005-02-17 |
Steiner Mitchell S. |
Selective androgen receptor modulators and methods of use thereof
|
US6995284B2
(en)
*
|
2000-08-24 |
2006-02-07 |
The University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
US6071957A
(en)
*
|
1996-11-27 |
2000-06-06 |
The University Of Tennessee Research Corporation |
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
|
AU7723198A
(en)
*
|
1997-06-04 |
1998-12-21 |
University Of Tennessee Research Corporation, The |
Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
|
US20040186185A1
(en)
*
|
1998-05-07 |
2004-09-23 |
Steiner Mitchell S. |
Method for treatment and chemoprevention of prostate cancer
|
SE9901875D0
(sv)
*
|
1999-05-25 |
1999-05-25 |
Astra Pharma Prod |
Novel compounds
|
DE10014141A1
(de)
*
|
2000-03-22 |
2001-10-11 |
Jomaa Hassan |
2-Phenylendiaminderivate als Herbizide
|
WO2002016310A1
(en)
|
2000-08-24 |
2002-02-28 |
The University Of Tennessee Research Corporation |
Selective androgen receptor modulators and methods of use thereof
|
US20040260108A1
(en)
*
|
2001-06-25 |
2004-12-23 |
Dalton James T. |
Metabolites of selective androgen receptor modulators and methods of use thereof
|
US7026500B2
(en)
*
|
2000-08-24 |
2006-04-11 |
University Of Tennessee Research Foundation |
Halogenated selective androgen receptor modulators and methods of use thereof
|
US7919647B2
(en)
*
|
2000-08-24 |
2011-04-05 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US20070173546A1
(en)
*
|
2000-08-24 |
2007-07-26 |
Dalton James T |
Selective androgen receptor modulators and method of use thereof
|
US6998500B2
(en)
*
|
2000-08-24 |
2006-02-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US7855229B2
(en)
*
|
2000-08-24 |
2010-12-21 |
University Of Tennessee Research Foundation |
Treating wasting disorders with selective androgen receptor modulators
|
US8445534B2
(en)
*
|
2000-08-24 |
2013-05-21 |
University Of Tennessee Research Foundation |
Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
|
US8008348B2
(en)
*
|
2001-12-06 |
2011-08-30 |
University Of Tennessee Research Foundation |
Treating muscle wasting with selective androgen receptor modulators
|
US6838484B2
(en)
*
|
2000-08-24 |
2005-01-04 |
University Of Tennessee Research Foundation |
Formulations comprising selective androgen receptor modulators
|
US7645898B2
(en)
*
|
2000-08-24 |
2010-01-12 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and method of use thereof
|
US7622503B2
(en)
*
|
2000-08-24 |
2009-11-24 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US20060287282A1
(en)
*
|
2001-06-25 |
2006-12-21 |
Steiner Mitchell S |
Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
|
JP4605557B2
(ja)
*
|
2001-12-06 |
2011-01-05 |
ユニバーシティ オブ テネシー リサーチ ファウンデーション |
選択的アンドロゲンレセプタ修飾因子を用いた筋萎縮治療
|
US20070161608A1
(en)
*
|
2001-12-06 |
2007-07-12 |
Dalton James T |
Selective androgen receptor modulators for treating muscle wasting
|
US8853266B2
(en)
*
|
2001-12-06 |
2014-10-07 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators for treating diabetes
|
CN101732298B
(zh)
*
|
2002-02-07 |
2012-09-19 |
田纳西大学研究基金会 |
用sarms治疗良性前列腺增生
|
US7803970B2
(en)
*
|
2002-02-28 |
2010-09-28 |
University Of Tennessee Research Foundation |
Multi-substitued selective androgen receptor modulators and methods of use thereof
|
AU2003217303A1
(en)
*
|
2002-02-28 |
2003-09-16 |
University Of Tennessee Research Foundation |
Haloacetamide and azide substituted compounds and methods of use thereof
|
US7344700B2
(en)
*
|
2002-02-28 |
2008-03-18 |
University Of Tennessee Research Corporation |
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
|
KR101088352B1
(ko)
*
|
2002-02-28 |
2011-11-30 |
유니버시티 오브 테네시 리서치 파운데이션 |
다치환된 선택적 안드로겐 수용체 조절자 및 이를 사용하는 방법
|
US7772433B2
(en)
*
|
2002-02-28 |
2010-08-10 |
University Of Tennessee Research Foundation |
SARMS and method of use thereof
|
US7741371B2
(en)
*
|
2002-06-17 |
2010-06-22 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
EP1534663A4
(en)
*
|
2002-06-17 |
2006-08-30 |
Univ Tennessee Res Foundation |
SELECTIVE MODULATORS OF THE N-BRIDGE ANDROGEN RECEPTOR AND METHODS OF USE
|
EP1562594A4
(en)
*
|
2002-10-15 |
2008-12-17 |
Univ Tennessee Res Foundation |
SELECTIVE ANDROGEN RECEPTOR MODULATORS WITH METHYLENE BRIDGES AND METHOD OF USE THEREOF
|
US20040197928A1
(en)
*
|
2002-10-15 |
2004-10-07 |
Dalton James T. |
Method for detecting selective androgen receptor modulators
|
US20040224979A1
(en)
*
|
2002-10-15 |
2004-11-11 |
Dalton James T. |
Treating obesity with selective androgen receptor modulators
|
US20060276539A1
(en)
*
|
2002-10-16 |
2006-12-07 |
Dalton James T |
Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS
|
EP1558233A2
(en)
*
|
2002-10-16 |
2005-08-03 |
GTX, Inc. |
Treating androgen decline in aging male (adam)-associated conditions with sarms
|
US20040087810A1
(en)
*
|
2002-10-23 |
2004-05-06 |
Dalton James T. |
Irreversible selective androgen receptor modulators and methods of use thereof
|
US8309603B2
(en)
|
2004-06-07 |
2012-11-13 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US20040167103A1
(en)
*
|
2003-02-24 |
2004-08-26 |
Dalton James T. |
Haloacetamide and azide substituted compounds and methods of use thereof
|
TW200533636A
(en)
*
|
2003-12-16 |
2005-10-16 |
Gtx Inc |
Prodrugs of selective androgen receptor modulators and methods of use thereof
|
US9884038B2
(en)
|
2004-06-07 |
2018-02-06 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulator and methods of use thereof
|
US20110237664A1
(en)
*
|
2004-06-07 |
2011-09-29 |
Dalton James T |
Selective androgen receptor modulators for treating diabetes
|
US9889110B2
(en)
|
2004-06-07 |
2018-02-13 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulator for treating hormone-related conditions
|
US20060258628A1
(en)
*
|
2004-07-20 |
2006-11-16 |
Steiner Mitchell S |
Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof
|
US10010521B2
(en)
|
2006-08-24 |
2018-07-03 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US9730908B2
(en)
|
2006-08-24 |
2017-08-15 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
PT2054049E
(pt)
|
2006-08-24 |
2016-06-02 |
Univ Tennessee Res Found |
Acilanilidas substituídas e métodos de utilização das mesmas
|
US9844528B2
(en)
|
2006-08-24 |
2017-12-19 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US7968603B2
(en)
|
2007-09-11 |
2011-06-28 |
University Of Tennessee Research Foundation |
Solid forms of selective androgen receptor modulators
|
EP2052607A1
(de)
|
2007-10-24 |
2009-04-29 |
Bayer CropScience AG |
Herbizid-Kombination
|
DE102008037622A1
(de)
|
2008-08-14 |
2010-02-25 |
Bayer Cropscience Ag |
Herbizid-Kombination mit Dimethoxytriazinyl-substituierten Difluormethansulfonylaniliden
|
US9969683B2
(en)
|
2012-07-13 |
2018-05-15 |
Gtx, Inc. |
Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
|
US9622992B2
(en)
|
2012-07-13 |
2017-04-18 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
US10987334B2
(en)
|
2012-07-13 |
2021-04-27 |
University Of Tennessee Research Foundation |
Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
|
US10314807B2
(en)
|
2012-07-13 |
2019-06-11 |
Gtx, Inc. |
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
|
US9744149B2
(en)
|
2012-07-13 |
2017-08-29 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
US10258596B2
(en)
|
2012-07-13 |
2019-04-16 |
Gtx, Inc. |
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
|
CN108143728A
(zh)
|
2012-07-13 |
2018-06-12 |
Gtx公司 |
选择性雄激素受体调节剂在治疗乳癌中的用途
|
CN104604857A
(zh)
*
|
2013-11-04 |
2015-05-13 |
南京华洲药业有限公司 |
一种含麦草畏与稗草胺的除草组合物及其应用
|